Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular Carcinomas
Cancers · 09.04.2025 · 17 (8) · 1265
DOI: 10.3390/cancers17081265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 09.04.2025. Verfasst von Michael Mohnasky und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Studies have indicated that forgoing lung shunt fraction measurement in select patients undergoing Yttrium 90 (Y90) transarterial radioembolization (TARE) may be safe without sacrificing efficacy. This study evaluated the safety and efficacy of a streamlined treatment in patients with small hepatocellular carcinoma (HCC) receiving resin-based TARE.
Methods
Patients who received single-session Y90 TARE between September 2023 and May 2024 were retrospectively evaluated. Treatment response was evaluated at the 3-month follow-up using the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Adverse events (AEs) ≥ Grade 3 were recorded post-procedurally at 3 months. The time from the interventional radiology clinic visit to the procedure date was compared to patients receiving the conventional TARE treatment.
Results
Ten consecutive patients were treated with 12 treatments. Each treatment targeted an isolated lesion with median size of 2.5 cm (IQR: 2.1, 2.9). Two patients received two treatments (one for treatment of a separate lesion and the other for the initial incomplete targeting of the tumor). The median delivered tumor dose was 377.7 Gy (IQR: 246.5, 570.1). No patients developed ≥ Grade 3 AEs post-TARE. Complete response was achieved in 11/12 patients (92%). The conventional cohort consisted of 60 patients, all OPTN T2 treated with radiation segmentectomy with glass microspheres. Patients undergoing SSMT had a median time from clinic visit to treatment of 26.5 days (IQR: 15.3, 39) vs. 61 days (IQR: 48, 88.8) in the conventional TARE group (p < 0.001).
Conclusions
Streamlined single-session resin-based Y90-TARE in patients with OPTN T2 stage HCC is feasible, efficacious, safe, and associated with reduced time to treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- School of Medicine, Saint George's University, West Indies P.O. Box 7, Grenada.
- Department of Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Department of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
ORCID-Profile: Michael Mohnasky, Sandra Gad, Hyeon Yu, Andrew M Moon
Zitieren
APA
Mohnasky, M., Gad, S., Fanous, M., Du Pisanie, J. L., Ivanovic, M., Mauro, D. M., Yu, H., Villalobos, A., Moon, A. M., Sanoff, H. K., Jia, J., & Kokabi, N. (2025). Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular Carcinomas. Cancers, 17(8), 1265. https://doi.org/10.3390/cancers17081265
Vancouver
Mohnasky M, Gad S, Fanous M, Du Pisanie JL, Ivanovic M, Mauro DM, et al. Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular Carcinomas. Cancers. 2025;17(8):1265. doi:10.3390/cancers17081265
BibTeX
@article{Mohnasky2025,
author = {Mohnasky, Michael and Gad, Sandra and Fanous, Marco and Du Pisanie, Johannes L and Ivanovic, Marija and Mauro, David M and Yu, Hyeon and Villalobos, Alex and Moon, Andrew M and Sanoff, Hanna K and Jia, Jingquan and Kokabi, Nima},
title = {Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular Carcinomas},
journal = {Cancers},
year = {2025},
volume = {17},
number = {8},
pages = {1265},
doi = {10.3390/cancers17081265}
}
EUVIMED